The CDC's FluView surveillance report for Week 17 (ending May 2, 2026), released today, confirms a cumulative influenza hospitalization rate of 86.0 per 100,000 population through FluSurv-NET sites covering 9% of the U.S. population—a third-highest level since the 2010-11 season amid an intense year with an estimated 32 million illnesses and 380,000 hospitalizations dominated by A(H3N2). This uptick from 85.7 per 100,000 in Week 16 aligns trader consensus at 100% for the 85–90 bin, reflecting skin-in-the-game agreement with authoritative data as weekly rates plummet to 0.2 per 100,000 amid low seasonal activity. Realistic challenges include rare CDC revisions from reporting lags, though final FluSurv-NET figures carry high reliability.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedFlu Hospitalization Rate Week 17, 2026?
Flu Hospitalization Rate Week 17, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$13,590 Vol.
$13,590 Vol.
May 8, 2026
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$13,590 Vol.
$13,590 Vol.
May 8, 2026
<80
$1,247 Vol.
No
80–85
$1,643 Vol.
No
85–90
$5,033 Vol.
Yes
90–95
$2,964 Vol.
No
95–100
$1,433 Vol.
No
100+
$1,271 Vol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC's FluView surveillance report for Week 17 (ending May 2, 2026), released today, confirms a cumulative influenza hospitalization rate of 86.0 per 100,000 population through FluSurv-NET sites covering 9% of the U.S. population—a third-highest level since the 2010-11 season amid an intense year with an estimated 32 million illnesses and 380,000 hospitalizations dominated by A(H3N2). This uptick from 85.7 per 100,000 in Week 16 aligns trader consensus at 100% for the 85–90 bin, reflecting skin-in-the-game agreement with authoritative data as weekly rates plummet to 0.2 per 100,000 amid low seasonal activity. Realistic challenges include rare CDC revisions from reporting lags, though final FluSurv-NET figures carry high reliability.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Market Opened: Apr 30, 2026, 2:36 PM ET
Volume
$13,590End Date
May 8, 2026Market Opened
Apr 30, 2026, 2:36 PM ETResolver
0x69c47De9D...Outcome proposed: No
No dispute
Final outcome: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC's FluView surveillance report for Week 17 (ending May 2, 2026), released today, confirms a cumulative influenza hospitalization rate of 86.0 per 100,000 population through FluSurv-NET sites covering 9% of the U.S. population—a third-highest level since the 2010-11 season amid an intense year with an estimated 32 million illnesses and 380,000 hospitalizations dominated by A(H3N2). This uptick from 85.7 per 100,000 in Week 16 aligns trader consensus at 100% for the 85–90 bin, reflecting skin-in-the-game agreement with authoritative data as weekly rates plummet to 0.2 per 100,000 amid low seasonal activity. Realistic challenges include rare CDC revisions from reporting lags, though final FluSurv-NET figures carry high reliability.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$13,590End Date
May 8, 2026Market Opened
Apr 30, 2026, 2:36 PM ETResolver
0x69c47De9D...Outcome proposed: No
No dispute
Final outcome: No
The CDC's FluView surveillance report for Week 17 (ending May 2, 2026), released today, confirms a cumulative influenza hospitalization rate of 86.0 per 100,000 population through FluSurv-NET sites covering 9% of the U.S. population—a third-highest level since the 2010-11 season amid an intense year with an estimated 32 million illnesses and 380,000 hospitalizations dominated by A(H3N2). This uptick from 85.7 per 100,000 in Week 16 aligns trader consensus at 100% for the 85–90 bin, reflecting skin-in-the-game agreement with authoritative data as weekly rates plummet to 0.2 per 100,000 amid low seasonal activity. Realistic challenges include rare CDC revisions from reporting lags, though final FluSurv-NET figures carry high reliability.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions